A company's securities were subject to delisting from Nasdaq after failing to regain compliance with listing requirements.
1 report, 1 independent
Updated Sep 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company's securities were subject to delisting from Nasdaq after failing to regain compliance with listing requirements.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Unity Biotechnology faces deregistration from Nasdaq after failing to meet listing standards due to diminished operations.Sub-event
The company plans to request a hearing to appeal the Nasdaq deficiency notice and delisting.1 source
Keep exploring
The entities involved
-
Dih
Brazilian association football player
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireDIH Holding US, Inc. Receives Nasdaq Staff Determination Letter DIH Receives Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market DIH Intends to Request Hearing to Appeal in